2011 annual financial data
Ernexa Therapeutics 2011 Net margin
Direct answer
Net margin was -14.32%.
Operating income was -3,276,000 USD and net income was -3,419,000 USD.
Operating cash flow was 574,000 USD.
Get free Ernexa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 23,870,000 USD
- Operating income
- -3,276,000 USD
- Net income
- -3,419,000 USD
- Operating cash flow
- 574,000 USD